18 September 2017 - - US-based breast cancer treatment specialist Concure Oncology, parent company of Breast Microseed Treatment, has appointed Scott Armstrong, former president and CEO of Group Health Cooperative, to its board of directors, the company said.
By joining Concure's Board and supporting the advancement of Breast Microseed Treatment, Armstrong continues his advocacy for patient-centric care.
He has spent his career advancing evidence-driven, innovative approaches to improving health, and is an evangelist for healthcare that reaches beyond the doctor's office into the community.
Earlier this year, Armstrong wrapped up a distinguished 31-year commitment to Group Health Cooperative, an integrated healthcare provider and not-for-profit health plan that has been nationally recognized for delivering some of the nation's highest quality care.
Group Health employed more than 1,000 providers practicing in 25 Group Health-owned and operated medical centers and contracted hospitals in Washington state.
The company, which employed more than 7,500 staff, had operating revenue of more than USD 3.8bn in 2016.
Armstrong, who has a Masters Degree in Health Services Administration from the University of Wisconsin, started with Group Health in 1986 and quickly moved through its leadership ranks.
He held positions including VP of network services, executive VP/chief administrative officer, executive VP/chief operating officer, and then led the company as president and CEO for 12 years.
Before leaving the company, he oversaw the acquisition of the nationally recognized health plan by Kaiser Permanente, which closed on February 1, 2017. He worked with his board and executive leadership team to consider the acquisition, negotiate the agreement, and successfully gain all necessary approvals to close the deal.
Concure Oncology is committed to easing the burden for women facing early-stage breast cancer by enhancing and simplifying radiation treatment. The company partners with breast care centers of excellence to provide Breast Microseed Treatment, a post-lumpectomy radiation procedure performed in a single visit.